[1]
Maul, J.-T. et al. 2024. Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT). Acta Dermato-Venereologica. 104, (Nov. 2024), adv40946. DOI:https://doi.org/10.2340/actadv.v104.40946.